Ovarian cancer accounts for only 4% of cancers in women, but it is the
leading cause of death from gynecologic malignancies in the United St
ates. The high mortality rate from ovarian cancer is primarily because
of the difficulty in detecting the disease in early stages; the disea
se tends to be asymptomatic until it is well advanced. There are curre
ntly no convincing data to support extensive screening although a numb
er of studies looking at this issue are under way. Annual rectovaginal
pelvic exam, testing of CA 125 level, and transvaginal ultrasonograph
y may be indicated in high-risk women. Oral contraceptive use appears
to reduce the risk of ovarian cancer.